by 徐豫御姊愛
作家徐豫御姊愛主持的知性時事節目，Mon-Fri每天更新|合作：[email protected] 如欲收到推播，可鎖定御姊愛的IG限動 @anita.writer
Language
🇨🇳
Publishing Since
10/28/2018
Email Addresses
1 available
Phone Numbers
0 available
February 20, 2025
《美學之眼｜哲青的藝術宮殿》線上課程🖼 視覺訓練 x 故事引導，建立你的「美學之眼」📚 掌握藝術原則，看懂藝術家想告訴我們什麼✒️ 以人性與情緒切入，從作品看見自己的影子🏛 帶你從全新視角，解讀世界經典博物館館藏📖 不需專業背景也能看懂藝術、獲得欣賞樂趣✨ 限時優於48折，結帳輸入：ATT350 再折$350！課程介紹 👉 https://hi.sat.cool/tiUFh 「徐豫切入點」節目合作來信：[email protected] 私訊分享請IG https://www.instagram.com/anita.writer/
December 19, 2024
Dr. An-Ni Guo joins Anita Xu to discuss the effectiveness of various birth control methods, including the 99% success rate of long-acting injectable contraceptives, highlighting the importance of consulting a gynecologist for personalized advice.
November 7, 2024
<簡報的技術>課程資訊： https://funi.best/courses/presentation/?coupon=anita350 結帳輸入優惠碼「anita350」再折 $350 元 「徐豫切入點」節目合作來信：[email protected] 私訊分享請IG https://www.instagram.com/anita.writer/
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
